Description
Identification of therapeutically relevant gene mutations for Cancer
OncQuerTM Focus Panel
Identification of therapeutically relevant gene mutations for Cancer
TAT:
Specimen Type:
Genomics Panel Test
Other Tests
-
263%
MPL Mutation Detection
Exon 10
-
260%
IGVH Somatic Hyper Mutation Assay
Colon and Lung Cancer marker
-
264%
OncQuer TM Germline Mutation Panel by NGS
Identification of gene mutations that increase risk of cancer or has therapeutic implications in an affected individual
OncQuer TM Germline Mutation Panel by NGS
Identification of gene mutations that increase risk of cancer or has therapeutic implications in an affected individual
-
264%
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
Reviews
There are no reviews yet.